Skip to main content

Table 1 Baseline characteristics of 629 spinal metastases patients

From: Healthcare costs attributable to the treatment of patients with spinal metastases: a cohort study with up to 8 years follow-up

  Copenhagen database (n = 419) Aarhus database (n = 210)
  n % n %
Male 245 58 134 64
Age (years)     
15-54 62 15 42 20
55-64 115 27 68 32
65-74 137 33 71 34
75-84 81 19 26 12
≥85 24 6 3 1
Primary cancer     
Prostate 97 23 67 32
Lung 99 24 22 10
Breast 75 18 41 20
Other 148 35 80 38
Predicted survival time* (months)     
0-6 198 47 107 51
6-12 122 29 76 36
>12 99 24 27 13
Treatment     
T1 419 100   
T2    51 24
T3    79 38
T4    80 38
  1. *Based on the Tokuhashi scoring system at baseline.
  2. T1 conservative, T2 decompression, T3 decompression + instrumentation, T4 decompression + instrumentation + reconstruction.